NASDAQ:XOMAP XOMA (XOMAP) Stock Price, News & Analysis $26.30 +0.30 (+1.15%) (As of 09:28 AM ET) Add Compare Share Share Today's Range$26.30▼$26.3050-Day Range$24.85▼$26.2552-Week Range$21.40▼$26.48Volume378 shsAverage Volume1,756 shsMarket CapitalizationN/AP/E RatioN/ADividend Yield8.21%Price TargetN/A Stock AnalysisStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsDividendFinancialsHeadlinesSEC FilingsShort InterestTrends Get XOMA alerts: Email Address Ad Behind the MarketsThe Only Retirement Stock You'll Ever Need? Discover NowThere is a little region of America called Loudoun County. The value of each square mile has shot up close to $10 billion... It's also the source of the single greatest investment opportunity of our generation...Get all the urgent details here >>> About XOMA Stock (NASDAQ:XOMAP)XOMA Corporation operates as a biotech royalty aggregator in the United States and the Asia Pacific. It has a portfolio of economic rights to future potential milestone and royalty payments associated with partnered commercial and pre-commercial therapeutic candidates. The company also focuses on early to mid-stage clinical assets primarily in Phase 1 and 2 with commercial sales potential that are licensed to partners; and acquires milestone and royalty revenue streams on late-stage clinical or commercial assets. It has a portfolio with various assets. XOMA Corporation was incorporated in 1981 and is headquartered in Emeryville, California.Read More XOMAP Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart XOMAP Stock News HeadlinesJuly 1 at 8:58 AM | americanbankingnews.comXOMA Co. (NASDAQ:XOMAP) Declares Quarterly Dividend of $0.54July 1 at 8:18 AM | americanbankingnews.comXOMA Co. (XOMAP) to Issue Quarterly Dividend of $0.54 on July 15thJuly 2, 2024 | Behind the Markets (Ad)Major Pharma Deals Propel This Undervalued AI StockYou need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.June 29 at 5:34 AM | americanbankingnews.comXOMA Co. (NASDAQ:XOMAP) Short Interest Up 70.0% in JuneMay 14, 2024 | markets.businessinsider.comBuy Rating Affirmed for Xoma with Enhanced Price Target Reflecting New Royalty Assets and Growth ProspectsApril 30, 2024 | msn.comLeerink Partners Initiates Coverage of XOMA (XOMA) with Outperform RecommendationApril 17, 2024 | thestreet.comXOMA Corporation 8.625% Series A Cumulative Perpetual Preferred StockMarch 21, 2024 | msn.comXOMA Corp - 8.375% DP PFD B declares $0.5234 dividendJuly 2, 2024 | Behind the Markets (Ad)Major Pharma Deals Propel This Undervalued AI StockYou need to check out this game-changing biotech stock. Their physics-based software can model how molecules behave and identify ideal drug candidates in record time. Big Pharma is taking notice.March 13, 2024 | finanznachrichten.deAdhoc: Kuros Biosciences AG: Kuros reports 163% growth in direct MagnetOs sales and 153% increase in total medical device sales for the full year 2023March 11, 2024 | markets.businessinsider.comAnalysts Conflicted on These Healthcare Names: Xoma (XOMA) and Lexicon Pharmaceuticals (LXRX)February 23, 2024 | msn.comCox Communications wins order overturning $1 billion US copyright verdictFebruary 17, 2024 | finance.yahoo.comXOMA Jun 2024 20.000 putFebruary 17, 2024 | finance.yahoo.comXOMA Sep 2024 12.500 putFebruary 16, 2024 | markets.businessinsider.comStrategic Acquisitions and Royalty Income Streams Justify Buy Rating for XomaFebruary 16, 2024 | marketwatch.comKinnate Biopharma Shares Rise on XOMA AcquisitionFebruary 16, 2024 | markets.businessinsider.comKinnate Biopharma To Be Acquired By XOMA In Cash Deal; Stock GainsJanuary 18, 2024 | finanznachrichten.deXOMA Corporation: XOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA AcquisitionJanuary 18, 2024 | finance.yahoo.comXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionJanuary 18, 2024 | finance.yahoo.comXOMA Expands its Commercial Royalty and Milestone Portfolio with DSUVIA® AcquisitionJanuary 8, 2024 | marketwatch.comXOMA Names Hughes Permanent CEO; Wyszomierski Becomes ChairmanJanuary 8, 2024 | finance.yahoo.comXOMA Names Owen Hughes as Chief Executive Officer and Appoints Jack L. Wyszomierski as Chairman of the Board of DirectorsDecember 22, 2023 | benzinga.comXOMA Stock (NASDAQ:XOMA) Dividends: History, Yield and DatesNovember 11, 2023 | morningstar.comXOMA Corp XOMANovember 7, 2023 | msn.comXOMA GAAP EPS of -$0.60 misses by $0.12, revenue of $0.83M misses by $0.36MOctober 27, 2023 | finanznachrichten.deObsEva SA: Organon Returns Ebopiprant to XOMAOctober 27, 2023 | finance.yahoo.comOrganon Returns Ebopiprant to XOMASee More Headlines Receive XOMAP Stock News and Ratings via Email Sign-up to receive the latest news and ratings for XOMA and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Ex-Dividend for 4/15 Dividend4/02/2024Dividend Payable4/15/2024Today7/02/2024Ex-Dividend for 7/15 Dividend7/03/2024Dividend Payable7/15/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Biotechnology Sub-IndustryN/A Current SymbolNASDAQ:XOMAP CUSIPN/A CIK791908 Webwww.xoma.com Phone510-204-7200FaxN/AEmployees13Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$5.81 million Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding SharesN/AFree FloatN/AMarket CapN/A OptionableNot Optionable BetaN/A Elon Musk's Next MoveWondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.Get This Free Report Key ExecutivesMr. Owen P. Hughes Jr. (Age 49)CEO & Director Comp: $193.75kMr. Thomas M. Burns (Age 50)Senior VP of Finance & CFO Comp: $759.24kMr. Brad Sitko (Age 43)Chief Investment Officer Comp: $867.08kKey Competitors180 Life SciencesNASDAQ:ATNFW60 Degrees PharmaceuticalsNASDAQ:SXTPWAlpha Tau MedicalNASDAQ:DRTSWApollomicsNASDAQ:APLMWArtelo BiosciencesNASDAQ:ARTLWView All Competitors XOMAP Stock Analysis - Frequently Asked Questions How have XOMAP shares performed in 2024? XOMA's stock was trading at $25.41 at the beginning of the year. Since then, XOMAP stock has increased by 3.5% and is now trading at $26.30. View the best growth stocks for 2024 here. Are investors shorting XOMA? XOMA saw a increase in short interest in June. As of June 15th, there was short interest totaling 1,700 shares, an increase of 70.0% from the May 31st total of 1,000 shares. Based on an average trading volume of 1,400 shares, the short-interest ratio is presently 1.2 days. View XOMA's Short Interest. How often does XOMA pay dividends? What is the dividend yield for XOMA? XOMA announced a quarterly dividend on Wednesday, May 15th. Stockholders of record on Wednesday, July 3rd will be given a dividend of $0.5391 per share on Monday, July 15th. This represents a $2.16 dividend on an annualized basis and a dividend yield of 8.20%. The ex-dividend date is Wednesday, July 3rd. Read our dividend analysis for XOMAP. Is XOMA a good dividend stock? XOMA (NASDAQ:XOMAP) pays an annual dividend of $2.16 per share and currently has a dividend yield of 9.29%. XOMAP has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. Read our dividend analysis for XOMAP. How do I buy shares of XOMA? Shares of XOMAP stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:XOMAP) was last updated on 7/2/2024 by MarketBeat.com Staff From Our PartnersNew Government Policy to Wipe Out Seniors WealthDon't wait until it's too late. The digital dollar is nearing the end of its trial period, and the window of o...Oasis Gold | SponsoredThe Only Retirement Stock You'll Ever Need? Discover NowThere is a little region of America called Loudoun County. The value of each square mile has shot up close ...Behind the Markets | Sponsored1k a day while computer does all work?What I discovered is now helping me take in more than 1k a day. It's like a "magic key" to passive income ...Digital Mavericks Media | SponsoredURGENT: I’m typing this as fast as I can.I was just informed about something very unsettling… The U.S. Federal Reserve’s computers were allegedly ha...Weiss Ratings | SponsoredOperation Replace Biden is a GoLast night’s debate proved me right: Joe Biden will be replaced. I’ve been making this warning for months… ...The Freeport Society | SponsoredWill Biden Be Replaced?There are growing rumors of a possible Joe Biden replacement following his first debate against Donald Trump. ...Stansberry Research | SponsoredBiden’s inner circle turns against him?On August 19, the Democratic party will take the stage in Chicago and officially nominate their presidential c...Paradigm Press | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding XOMA Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share XOMA With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
